Neurent raises $74M to commercialize treatment for nasal condition
The device creates lesions to disrupt nerve signals that drive mucus production.
Neurent raises $74M to commercialize treatment for nasal condition Read More »
The device creates lesions to disrupt nerve signals that drive mucus production.
Neurent raises $74M to commercialize treatment for nasal condition Read More »
At a House subcommittee hearing on Wednesday, lawmakers on both sides of the aisle decried the nation’s high drug costs, but Democrats argued Medicaid cuts and lapsed Affordable Care Act subsidies are worsening the problem.
Lowering drug costs is on Republicans’ minds. Democrats say GOP policies don’t help. Read More »
Infigratinib topped “even the most optimistic expectations” for efficacy and safety in the late-stage PROPEL 3 study in achondroplasia, Truist Securities analysts said Thursday.
‘Highly Impressive’ Data Propels BridgeBio’s Achondroplasia Drug Forward Read More »
The cut grants, which were viewed by Healthcare Dive, fund a wide swath of areas including workforce initiatives, STI prevention measures, health equity proposals and others in California, Colorado, Illinois and Minnesota.
CDC moves to cut $600M in grants to Democrat-led states Read More »
The sudden departure stands in contrast to other EU pharma leaders who have been given much longer transitions in recent months, including GSK’s Emma Walmsley and Novo Nordisk’s Lars Fruergaard Jørgensen.
The oral version of Wegovy has made GLP-1 medicines more accessible and acceptable to many patients who had steered clear of injectable versions, healthcare analytics firm Truveta suggests.
Oral Wegovy Brings in Thousands of New GLP-1 Patients Read More »
AbbVie contends that Botox should have been excluded from the IRA drug price negotiation program because it is a plasma-derived product.
AbbVie Sues HHS, CMS for Including Botox in Drug Price Negotiation Program Read More »
In this episode of Denatured, Jennifer C. Smith-Parker speaks with Dr. Rob Monroe and Jennifer Fakish at Danaher Corporation. They discuss how antibody drug conjugates (ADCs) are transforming cancer care. With AI-powered pathology, doctors can now measure HER2 more precisely to match patients with the best treatments.
Digital Pathology, AI and the Future of ADCs and HER2 Cancer Treatment Read More »
An unnamed FDA official also told reporters that it would be good for Moderna to “show some humility” and admit that it didn’t follow the regulator’s recommendations in testing its mRNA flu vaccine.
Resulta fascinante observar cómo la cultura del juego en España, tradicionalmente ligada a la lotería social, se ha desplazado hacia el entorno digital de alta gama. El jugador español de 2026 valora, por encima de todo, la personalización y la eficiencia financier …
La seducción del riesgo calculado: Razones del éxito de los bonos High Roller en España Read More »